FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Florida Lays Out Plan to Import Canadian Drugs August 27, 2019 FDA Releases Final Guidance on Drugs for Hay Fever, Non-Allergic Rhinitis September 5, 2018 Following CRL, Spectrum Drops NSCLC Drug Candidate November 28, 2022